Comprehensive Chronic Care for Smoking Abstinence

Phase-Based Progress Estimates
Advocate Aurora, Milwaukee, WI
Smoking Abstinence+1 More
Comprehensive Chronic Care - Other
All Sexes
What conditions do you have?

Study Summary

This study will evaluate Comprehensive Chronic Care (CCC), a healthcare treatment approach designed to increase smoking treatment engagement and abstinence among primary care patients who smoke. This research will compare CCC with Standard of Care (SC) on the following outcomes: abstinence at 18 months (primary outcome), treatment reach, and cost-effectiveness. Participation in the study will last 18 months.

Eligible Conditions

  • Smoking Abstinence
  • Smoking, Cessation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Up to 18 months

12 months
Number of Participants with 7-day point-prevalence abstinence at 12 months
6 months
Number of Participants with 7-day point-prevalence abstinence at 6 months
Up to 18 months
Cost Effectiveness measured by incremental cost-effectiveness ratio (ICER)
Group differences in Cessation Treatment
Total Cost of Intervention
up to 18 months
Number of Participants with biochemically confirmed point-prevalence abstinence at 18 months

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Standard Care
1 of 2
Comprehensive Chronic Care
1 of 2
Active Control
Experimental Treatment

1000 Total Participants · 2 Treatment Groups

Primary Treatment: Comprehensive Chronic Care · No Placebo Group · N/A

Comprehensive Chronic Care
Experimental Group · 1 Intervention: Comprehensive Chronic Care · Intervention Types: Other
Standard Care
ActiveComparator Group · 1 Intervention: Standard Care · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 18 months
Closest Location: Advocate Aurora · Milwaukee, WI
Photo of Milwaukee  1Photo of Milwaukee  2Photo of Milwaukee  3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Smoking Abstinence
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Smoking is a major risk factor for chronic obstructive pulmonary disease.
You have smoked cigarettes every day in the past 30 days.
You are able to understand the nature of the study and consent.
You must be able to speak and read English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.